Firefly Neuroscience AIFF Institutional Ownership

Updated Oct 5, 2026

Firefly Neuroscience, Inc. (NASDAQ:AIFF) was reported as a holding by 23 institutional investors in 13F filings for the quarter ended June 30, 2026.

• These investors held 7.86% of outstanding shares in Q2 2026, up from 7.42% the quarter before.
• Total holdings of Firefly Neuroscience shares rose 34.31% from Q1 2026, and the number of holders was unchanged from Q2 2025.
• Among the 23 holders of Firefly Neuroscience, 10 added to their positions, 6 reduced their stakes and 7 left their positions unchanged.
• The aggregate institutional position in Firefly Neuroscience was 1.62Mn shares at the end of Q2 2026, up 413.11K from the prior quarter and up 988.99K from a year earlier.
• Murchinson Ltd. was the top holder of Firefly Neuroscience as of June 30, 2026, with 650K shares, or 3.16% of shares outstanding.
• The biggest increases in AIFF positions during Q2 2026 came from Cygnus Capital Advisors, LLC (+24.51K shares), BlackRock, Inc. (+17.81K shares), Northern Trust Corp (+17.73K shares) and Tower Research Capital LLC (+3.19K shares).
• The largest position reductions in AIFF for Q2 2026 were by Jane Street Group, LLC (-112.39K shares), UBS Group AG (-73.08K shares), Geode Capital Management, LLC (-34.79K shares), Citigroup Inc (-26.57K shares) and SBI Securities Co., Ltd. (-1.27K shares).
• Per Business Quant data, the 10 largest holders of Firefly Neuroscience at the end of Q2 2026 were Murchinson Ltd. (650K shares), BlackRock, Inc. (187.17K shares), Boothbay Fund Management, LLC (178.75K shares), Geode Capital Management, LLC (121.52K shares), Vanguard Capital Management LLC (111.91K shares), Jane Street Group, LLC (67.83K shares), UBS Group AG (59.12K shares), Vanguard Fiduciary Trust Co (50.99K shares), State Street Corp (46.3K shares) and Cygnus Capital Advisors, LLC (44.55K shares).